0001209191-23-030223.txt : 20230517 0001209191-23-030223.hdr.sgml : 20230517 20230517163943 ACCESSION NUMBER: 0001209191-23-030223 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230515 FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Soni Manmeet Singh CENTRAL INDEX KEY: 0001569769 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 23932337 MAIL ADDRESS: STREET 1: C/O PHARMACYCLICS, INC. STREET 2: 995 EAST ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 BUSINESS PHONE: 972-865-2219 MAIL ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-15 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001569769 Soni Manmeet Singh 5320 LEGACY DRIVE PLANO TX 75024 0 1 0 0 COO, CFO and President 0 Class A common stock 2023-05-15 4 S 0 12440 84.3201 D 125864 D Class A common stock 2023-05-15 4 S 0 8867 84.8648 D 116997 D Class A common stock 2023-05-15 4 S 0 200 85.6425 D 116797 D Class A common stock 2023-05-16 4 S 0 625 80.934 D 116172 D The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $83.595 to $84.59 The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $84.595 to $85.545. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $85.635 to $85.65. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Tracy Herson, attorney-in-fact 2023-05-17